Role of apoptosis and CD95/CD95 ligand expression in chronic hepatitis C and HIV infection

被引：0
|
作者：
Filipowicz, E [1 ]
Ololade, O [1 ]
Xiao, SY [1 ]
Adeboyega, PA [1 ]
机构：
[1] Univ Texas, Med Branch, Galveston, TX 77550 USA
来源：
LABORATORY INVESTIGATION | 2001年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1151
引用
收藏
页码：196A / 196A
页数：1
相关论文
共 50 条
  • [11] Differential and mutually exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas and chronic pancreatitis
    Hasel, C
    Rau, B
    Perner, S
    Sträter, J
    Möller, P
    LABORATORY INVESTIGATION, 2001, 81 (03) : 317 - 326
  • [12] Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma
    Glick, RD
    Swendeman, SL
    Coffey, DC
    Rifkind, RA
    Marks, PA
    Richon, VM
    La Quaglia, MP
    CANCER RESEARCH, 1999, 59 (17) : 4392 - 4399
  • [13] Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of γδ T cells to cause apoptosis
    Manfredi, AA
    Heltai, S
    Rovere, P
    Sciorati, C
    Paolucci, C
    Gelati, G
    Rugarli, C
    Vaiani, R
    Clementi, E
    Ferrarini, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (06) : 1798 - 1806
  • [14] The role of CD95 and CD95 ligand in cancer (vol 22, pg 885, 2015)
    Peter, M. E.
    Hadji, A.
    Murmann, A. E.
    Brockway, S.
    Putzbach, W.
    Pattanayak, A.
    Ceppi, P.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (05): : 885 - 886
  • [15] The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
    Manlio Tolomeo
    Luisa Dusonchet
    Maria Meli
    Stefania Grimaudo
    Natale D'Alessandro
    Giuliana Papoff
    Giovina Ruberti
    Luciano Rausa
    Cell Death & Differentiation, 1998, 5 : 735 - 742
  • [16] The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
    Tolomeo, M
    Dusonchet, L
    Meli, M
    Grimaudo, S
    D'Alessandro, N
    Papoff, G
    Ruberti, G
    Rausa, L
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (09): : 735 - 742
  • [17] CD95 and Fas ligand expression and apoptosis in rheumatoid arthritis.
    Cantwell, MJ
    Hua, T
    Zvaifler, NJ
    Kipps, TJ
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 287 - 287
  • [18] Fas antigen (CD95) expression and apoptosis in hepatocytes of patients with chronic viral hepatitis
    Kiyici, M
    Gurel, S
    Budak, F
    Dolar, E
    Gulten, M
    Nak, SG
    Memik, F
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (10) : 1079 - 1084
  • [19] CD95 (APO-1/FAS) AND THE CD95 LIGAND IN NORMAL AND MALIGNANT B-CELL APOPTOSIS
    DANIEL, PT
    MAPARA, MY
    BOMMERT, K
    BARGOU, RC
    KRAMMER, P
    DORKEN, B
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 831 - 831
  • [20] CD95 tyrosine phosphorylation is required for CD95 oligomerization
    Eberle, Andrea
    Reinehr, Roland
    Becker, Stephan
    Keitel, Verena
    Haeussinger, Dieter
    APOPTOSIS, 2007, 12 (04) : 719 - 729
12345